Absci (ABSI) Research & Development (2020 - 2026)
Absci's Research & Development was $22.62 million in Q2 2026, up 10.5% from $20.46 million a year earlier and up 17.3% from the prior quarter.
Powered by 
Analysis
Absci (ABSI) Research & Development (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Absci's Research & Development was $86.49 million through Jun 30, 2026, up 18.2% year-over-year; for FY2025, it came in at $81.42 million, up 27.5% from FY2024.
- Research & Development shows a five-year compound annual growth rate of 48.0% (FY2020 to FY2025).
- In earlier years, Research & Development was $63.86 million in FY2024 (+32.9%), $48.07 million in FY2023 (-18.4%), $58.91 million in FY2022 (+32.1%) and $44.59 million in FY2021 (+289.5%).
- Quarterly Research & Development has moved between $10.73 million (Q3 2021) and $25.35 million (Q4 2025) over five years.
- Compared with a year earlier, Research & Development has increased for nine straight quarters, with growth averaging 31.7% over the last eight quarters.
- The best year-over-year quarter for Research & Development over five years was Q3 2021 (growth of 298.6%); the worst was Q3 2023 (a decline of 29.0%).
- Per Business Quant data, ABSI's Research & Development in the three quarters before Q2 2026 was $19.28 million (Q1 2026), $25.35 million (Q4 2025) and $19.25 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Absci | 1.63 Bn | 1.01 Bn | - | 22.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.62 Mn |
| Mar 31, 2026 | 19.28 Mn |
| Dec 31, 2025 | 25.35 Mn |
| Sep 30, 2025 | 19.25 Mn |
| Jun 30, 2025 | 20.46 Mn |
| Mar 31, 2025 | 16.36 Mn |
| Dec 31, 2024 | 18.38 Mn |
| Sep 30, 2024 | 17.99 Mn |
| Jun 30, 2024 | 15.26 Mn |
| Mar 31, 2024 | 12.24 Mn |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 11.03 Mn |
| Jun 30, 2023 | 12.11 Mn |
| Mar 31, 2023 | 12.66 Mn |
| Dec 31, 2022 | 11.32 Mn |
| Sep 30, 2022 | 15.53 Mn |
| Jun 30, 2022 | 16.24 Mn |
| Mar 31, 2022 | 15.83 Mn |
| Dec 31, 2021 | 15.77 Mn |
| Sep 30, 2021 | 10.73 Mn |
API Access
Absci Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ABSI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ABSI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ABSI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();